Divis Laboratories Share Price Today - Live Blog for November 17, 2025

Divis Laboratories Ltd's stock has risen by a substantial 0.17%, and as of now, it's trading at ₹6,531.95 per share. This upward trajectory is attracting keen interest from investors.

Divis Laboratories Ltd observed a remarkable 0.53% surge in its share price and is presently trading at ₹6,531.95. The increased investor interest is driving this surge.

Divis Laboratories Ltd's share price remained flat, currently at ₹6,497.60. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

Divis Laboratories Ltd shares saw a -0.02% decrease, reaching a current market price of ₹6,497.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 69.5600, an ROE of 16.1228% and a debt to equity ratio of 0.0058.

Divis Laboratories Ltd shares experienced a -0.06% reduction, with the current market price at ₹6,499.20. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Divis Laboratories Ltd experienced a substantial 0.05% boost in its share price and has garnered significant attention from the market. It's now trading at ₹6,503.15, making it an appealing option for investors.

Divis Laboratories Ltd has had quite the run lately, experiencing a substantial 0.01% uptick in its share price. As a result, it's now actively trading at ₹6,500.00 per share, making it an attractive option for investors.

With a -0.14% decrease, Divis Laboratories Ltd's share price is currently at ₹6,499.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 69.5600, while the industry PE is 33.4307.

The stock of Divis Laboratories Ltd has experienced a -0.17% drop, and it's now trading at ₹6,504.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Divis Laboratories Ltd's share price has fallen by -0.17%, a situation worth noting. At present, the stock is trading at ₹6,504.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 69.5600, while the industry PE ratio is 33.4307.

Divis Laboratories Ltd experienced a -0.17% dip in its share price and is currently trading at ₹6,504.00. The stock has a PE ratio of 69.5600, an ROE of 16.1228% and a debt to equity ratio of 0.0058.

The stock of Divis Laboratories Ltd is facing a -0.20% decline and is currently trading at ₹6,514.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

There was no change in the share price of Divis Laboratories Ltd, and it continues to trade at ₹6,527.25. The stock has a PE ratio of 69.5600, an ROE of 16.1228%, and a debt to equity ratio of 0.0058.

Divis Laboratories Ltd stock stayed at its current value, with no movement, and is trading at ₹6,527.25. The stock has a PE ratio of 69.5600, an ROE of 16.1228%, and a debt to equity ratio of 0.0058.

With a remarkable 0.17% increase in value, the share price of Divis Laboratories Ltd currently stands at ₹6,527.25. Notably, this stock has a Price-to-Earnings (PE) ratio of 69.5600, while the industry's PE ratio is 33.4307.

The stock of Divis Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹6,515.95 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Divis Laboratories Ltd share price surged by 0.22%. With its current market price standing at ₹6,530.80 per share, this stock is garnering increased attention from the investment community.

The share price of Divis Laboratories Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹6,516.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

In the financial arena, Divis Laboratories Ltd's stock price has increased by 0.14%, with its current market value per share resting at ₹6,514.20. This development highlights the stock's appeal to investors.

Divis Laboratories Ltd's share price has fallen by -0.30%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹6,505.25, and market participants are assessing the implications. The stock has a PE ratio of 69.5600, an ROE of 16.1228% and a debt to equity ratio of 0.0058.

The stock of Divis Laboratories Ltd is on the rise, registering an impressive 0.21% increase and currently trading at ₹6,524.80 per share. Investors are taking notice of this upward momentum.

Divis Laboratories Ltd's share price rallied by 0.14%, reaching the current market price of ₹6,510.95. This surge is indicative of the stock's recent positive performance.

The share price of Divis Laboratories Ltd plunged by -0.17%, leaving investors concerned. At this moment, the stock can be acquired at ₹6,502.00, but investors are assessing whether this is a temporary dip or a long-term trend.

In a noteworthy development, Divis Laboratories Ltd witnessed a remarkable 0.01% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹6,514.00 per share. The stock has an ROE of 16.1228% and debt to equity ratio of 0.0058.

In recent times, Divis Laboratories Ltd witnessed a decline of -0.44% in its share price, and it currently trades at ₹6,513.10 per share. The stock has an ROE of 16.1228% and debt to equity ratio of 0.0058.

Divis Laboratories Ltd witnessed a substantial 0.36% increase in its share price and is currently trading at ₹6,541.75. This remarkable performance has caught the eye of investors.

Divis Laboratories Ltd stock price decreased by -0.09%, with the current market value at ₹6,518.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Divis Laboratories Ltd's shares saw an increase of 0.07%, reaching the current market price of ₹6,524.80. This development underscores the stock's growing popularity.